Premium
Drug‐induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept
Author(s) -
Kluk J.,
Goulding J. M. R.,
Bhat J.,
Finch T. M.
Publication year - 2011
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.2011.04102.x
Subject(s) - medicine , etanercept , bullous pemphigoid , dermatology , drug , pemphigoid , psoriasis , pustular psoriasis , pharmacology , immunology , rheumatoid arthritis , antibody
Summary Bullous pemphigoid (BP) is one of the most common acquired immunobullous diseases. Rarely, the development of BP is attributed to drug exposure. We present two cases of BP, one triggered by intravenous iodine, and one associated with etanercept treatment in a patient with psoriasis; the first time, to our knowledge, that either of these associations has been reported. The recognition of occasional cases of drug‐induced BP such as ours, with timely cessation of the offending agent, may produce rapid clinical improvement with decreased exposure to potent immunosuppressive therapy.